Ginsenoside Rg1 Suppresses Type 2 PRRSV Infection via NF-κB Signaling Pathway In Vitro, and Provides Partial Protection against HP-PRRSV in Piglet
- PMID: 31717616
- PMCID: PMC6893584
- DOI: 10.3390/v11111045
Ginsenoside Rg1 Suppresses Type 2 PRRSV Infection via NF-κB Signaling Pathway In Vitro, and Provides Partial Protection against HP-PRRSV in Piglet
Abstract
Porcine reproductive and respiratory syndrome virus (PRRSV) is a huge threat to the modern pig industry, and current vaccine prevention strategies could not provide full protection against it. Therefore, exploring new anti-PRRSV strategies is urgently needed. Ginsenoside Rg1, derived from ginseng and notoginseng, is shown to exert anti-inflammatory, neuronal apoptosis-suppressing and anti-oxidant effects. Here we demonstrate Rg1-inhibited PRRSV infection both in Marc-145 cells and porcine alveolar macrophages (PAMs) in a dose-dependent manner. Rg1 treatment affected multiple steps of the PRRSV lifecycle, including virus attachment, replication and release at concentrations of 10 or 50 µM. Meanwhile, Rg1 exhibited broad inhibitory activities against Type 2 PRRSV, including highly pathogenic PRRSV (HP-PRRSV) XH-GD and JXA1, NADC-30-like strain HNLY and classical strain VR2332. Mechanistically, Rg1 reduced mRNA levels of the pro-inflammatory cytokines, including IL-1β, IL-8, IL-6 and TNF-α, and decreased NF-κB signaling activation triggered by PRRSV infection. Furthermore, 4-week old piglets intramuscularly treated with Rg1 after being challenged with the HP-PRRSV JXA1 strain display moderate lung injury, decreased viral load in serum and tissues, and an improved survival rate. Collectively, our study provides research basis and supportive clinical data for using Ginsenoside Rg1 in PRRSV therapies in swine.
Keywords: NF-κB signaling pathway; antiviral activity; ginsenoside Rg1; porcine reproductive and respiratory syndrome virus; pro-inflammatory factor.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6893584/bin/viruses-11-01045-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6893584/bin/viruses-11-01045-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6893584/bin/viruses-11-01045-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6893584/bin/viruses-11-01045-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6893584/bin/viruses-11-01045-g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6893584/bin/viruses-11-01045-g006.gif)
Similar articles
-
Molecular and Cellular Mechanisms for PRRSV Pathogenesis and Host Response to Infection.Virus Res. 2020 Sep;286:197980. doi: 10.1016/j.virusres.2020.197980. Epub 2020 Apr 18. Virus Res. 2020. PMID: 32311386 Free PMC article. Review.
-
Multiple antiviral approaches of (-)-epigallocatechin-3-gallate (EGCG) against porcine reproductive and respiratory syndrome virus infection in vitro.Antiviral Res. 2018 Oct;158:52-62. doi: 10.1016/j.antiviral.2018.07.012. Epub 2018 Jul 23. Antiviral Res. 2018. PMID: 30048655
-
Inhibition of proanthocyanidin A2 on porcine reproductive and respiratory syndrome virus replication in vitro.PLoS One. 2018 Feb 28;13(2):e0193309. doi: 10.1371/journal.pone.0193309. eCollection 2018. PLoS One. 2018. PMID: 29489892 Free PMC article.
-
Carbon Monoxide Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication by the Cyclic GMP/Protein Kinase G and NF-κB Signaling Pathway.J Virol. 2016 Dec 16;91(1):e01866-16. doi: 10.1128/JVI.01866-16. Print 2017 Jan 1. J Virol. 2016. PMID: 27795439 Free PMC article.
-
Immunopathogenesis of porcine reproductive and respiratory syndrome in the respiratory tract of pigs.Vet J. 2013 Feb;195(2):148-55. doi: 10.1016/j.tvjl.2012.11.012. Epub 2012 Dec 20. Vet J. 2013. PMID: 23265866 Free PMC article. Review.
Cited by
-
The Significance of the 98th Amino Acid in GP2a for Porcine Reproductive and Respiratory Syndrome Virus Adaptation in Marc-145 Cells.Viruses. 2024 Apr 30;16(5):711. doi: 10.3390/v16050711. Viruses. 2024. PMID: 38793594 Free PMC article.
-
Epitope screening and vaccine molecule design of PRRSV GP3 and GP5 protein based on immunoinformatics.J Cell Mol Med. 2024 Feb;28(3):e18103. doi: 10.1111/jcmm.18103. Epub 2024 Jan 12. J Cell Mol Med. 2024. PMID: 38217314 Free PMC article.
-
Antiviral Potential of the Genus Panax: An updated review on their effects and underlying mechanism of action.J Ginseng Res. 2023 Mar;47(2):183-192. doi: 10.1016/j.jgr.2022.11.003. Epub 2022 Nov 17. J Ginseng Res. 2023. PMID: 36926608 Free PMC article. Review.
-
The Antiviral Activity of Caprylic Monoglyceride against Porcine Reproductive and Respiratory Syndrome Virus In Vitro and In Vivo.Molecules. 2022 Oct 26;27(21):7263. doi: 10.3390/molecules27217263. Molecules. 2022. PMID: 36364088 Free PMC article.
-
Ginsenosides are active ingredients in Panax ginseng with immunomodulatory properties from cellular to organismal levels.J Ginseng Res. 2022 Nov;46(6):711-721. doi: 10.1016/j.jgr.2021.12.007. Epub 2021 Dec 22. J Ginseng Res. 2022. PMID: 36312737 Free PMC article. Review.
References
-
- Shi M., Lam T.T., Hon C.C., Murtaugh M.P., Davies P.R., Hui R.K., Li J., Wong L.T., Yip C.W., Jiang J.W., et al. Phylogeny-based evolutionary, demographical, and geographical dissection of North American type 2 porcine reproductive and respiratory syndrome viruses. J. Virol. 2010;84:8700–8711. doi: 10.1128/JVI.02551-09. - DOI - PMC - PubMed
-
- Shi M., Lemey P., Singh Brar M., Suchard M.A., Murtaugh M.P., Carman S., D’Allaire S., Delisle B., Lambert M.E., Gagnon C.A., et al. The spread of type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) in North America: A phylogeographic approach. Virology. 2013;447:146–154. doi: 10.1016/j.virol.2013.08.028. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous